According to our findings, NMNGs in pan-cancer were significantly correlated with a number of signaling pathways, including TNFA signaling via NFKB, KRAS signaling, interferon-gamma response, inflammatory response, and epithelial-mesenchymal transition (EMT) (Figure 2G). The gene discussed is KRAS; the disease is cancer.